Published: 8 October 2025
Author(s): Laura González-Rodríguez, Manuel Martí-Antonio, Sonia Mota-Zamorano, Celia Chicharro, Bárbara Cancho, Enrique Luna, Álvaro Álvarez, Zoraida Verde, Fernando Bandrés, Nicolás R Robles, Guillermo Gervasini
Section: Original Article
Cardiovascular (CV) complications are the leading cause of death in patients with chronic kidney disease (CKD). Endothelin-1 (ET-1), a potent vasoconstrictor involved in both renal and vascular dysfunction, may represent a promising biomarker for the disease.